Writing off CSL entirely may be premature. The post CSL shares halved, can analysts be right about a 100% rebound? appeared ...

CSL (ASX:CSL) has outlined a restructuring plan that includes separating its Seqirus influenza vaccine business into a ...

New US-Iran missile attacks and an interest rate rise in Australia sent the market lower today. The post CSL and Wesfarmers ...

CSL and Reliance Worldwide are the latest ASX-listed companies to pull out of the high-profile investment conference, which ...

CSL shares (ASX:CSL) struck a fresh multi-year low at A$125.78, capping a 49.91% decline over twelve months as repeated guidance cuts and margin pressures continue to erode confidence in what was once ...

CSL Limited shares (ASX: CSL) fell to A$128.68 on Wednesday, marking a nine-year low, as markets continued to sell shares ...

These ASX healthcare shares have disappointed investors, but their long-term growth stories may still be intact. The post Down over 50%: Are CSL and Cochlear strong buys in May? appeared first on The ...

Australia’s sharemarket has diverged sharply so far in 2026, with a group of ASX 200 laggards erasing more than $217 billion ...

The S&P/ASX 200’s worst performing stocks this year and over one and three years are a nasty combination of one-time growth ...

Before that announcement, the ASX 200 index futures were 0.7 per cent lower at 8912 points after Wall Street’s key indexes – ...